Source:http://linkedlifedata.com/resource/pubmed/id/17222628
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2007-1-15
|
pubmed:abstractText |
Although the palliative benefits of hormonal therapy for metastatic prostate cancer are widely recognized, little information is available regarding the effect of hormonal therapy on cancer specific and overall survival, and the types of patients who might benefit the most or least from hormonal therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-5347
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
177
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
535-9
|
pubmed:meshHeading |
pubmed-meshheading:17222628-Aged,
pubmed-meshheading:17222628-Antineoplastic Agents, Hormonal,
pubmed-meshheading:17222628-Diethylstilbestrol,
pubmed-meshheading:17222628-Gonadotropin-Releasing Hormone,
pubmed-meshheading:17222628-Humans,
pubmed-meshheading:17222628-Male,
pubmed-meshheading:17222628-Neoplasm Metastasis,
pubmed-meshheading:17222628-Orchiectomy,
pubmed-meshheading:17222628-Prostatic Neoplasms,
pubmed-meshheading:17222628-Survival Rate
|
pubmed:year |
2007
|
pubmed:articleTitle |
Population based study of hormonal therapy and survival in men with metastatic prostate cancer.
|
pubmed:affiliation |
Department of Environmental and Occupational Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|